Dr. Hurvitz on Outcomes With Sacituzumab Govitecan in TNBC
September 2, 2021, 12:51 am
Sara A. Hurvitz, MD, discusses outcomes with sacituzumab govitecan-hziy in patients with metastatic triple-negative breast cancer.
Curated, Global, Hometown News for the City and Citizens of Santa Monica California
Dr. Hurvitz on Outcomes With Sacituzumab Govitecan in TNBC
COPYRIGHT © Indian Hill Media Inc. Another Smiling Dog Web Development. Hosted by InlandEmpire.IO ALL RIGHTS RESERVED.
COPYRIGHT © Indian Hill Media Inc. Another Smiling Dow Web Development. Hosted by InlandEmpire.IO ALL RIGHTS RESERVED.
